A new study by researchers from Marshall University and the University of Missouri highlights how exosomes—tiny vesicles ...

Scientists have long struggled to target proteins that lack defined structure and are involved in cancer, neurodegenerative ...

Several ASX healthcare companies are leading the charge in finding new treatments for complex neurological disorders.

About NeOnc Technologies, Holdings, Inc. NeOnc Technologies Holdings, Inc. is a clinical-stage life sciences company focused on the development and commercialization of central nervous system ...

Rakovina will present two abstracts at the meeting, the first: Discovery of novel PARP1-selective inhibitors for treatment of brain tumors using artificial intelligence , explores the use of ...

A new model of brain metabolism – the most complex ever generated –shows how altering key chemicals could restore aged cells ...

"Bader brings a wealth of capital markets and M&A experience to NeOnc,” said Dr. Thomas Chen, Chief Executive Officer of NeOnc. “His extensive finance background will serve us well as we embark on our ...

Mia Love, the first Black Republican woman elected to Congress, died three years after being diagnosed with glioblastoma, a ...

Learn how nanoparticles cross the blood-brain barrier (BBB) and explore their potential in treating neurological disorders ...

For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...